Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: The role of voriconazole

Haematologica

Volumn 93, Issue 1, 2008, Pages 159-160

  Girmenia, Corrado ^a   Pizzarelli, Giampaolo ^b   Pozzi, Emanuela ^a   Cimino, Giuseppe ^c   Gentile, Giuseppe ^a   Martino, Pietro ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b PFIZER INC   (United States)

^c University La Sapienza of Rome ^*

Author keywords

Aspergillus; Hematologic malignancies; Rhinosinusitis; Voriconazole

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; TRIAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; ASPERGILLUS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEALTH CENTER; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; RHINOSINUSITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ASPERGILLOSIS; CHILD; COHORT STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 38549121336     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11811     Document Type: Article

References (10)

1. Aisner J, Schimpff SC, Wiernik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977;86:539-43.
2. Voillier AF, Peterson DE, de Jongh CA, Newman KA, Gray WC, Sutherland JC, et al. Aspergillus sinusitis in cancer patients. Cancer 1986;58:366-71.
3. Talbot GH, Huang A, Provencher M. Invasive Aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 1991;13:219-32.
4. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-15.
5. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-71.
6. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
7. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an International Consensus. Clin Infect Dis 2002;34:7-14.
8. Upton A Kirby KA, Carpenter P, Boeckh, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007;44:531-40.
9. Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortalità - SEIFEM-C report. Clin Infect Dis 2007;44:1524-5.
10. Leveque D, Nivoix Y, Jehl F, Herbrecht R. Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents 2006; 27:274-84.